DTM™ SCS therapy
Spinal cord stimulation
DTM™ SCS is a proprietary, multiplexed algorithm coordinating multiple signals at multiple anatomical targets. In a randomized control trial (RCT) at 12 months, DTM™ SCS provided superior, sustained pain relief compared to conventional stimulation.1
DTM™ SCS endurance therapy
DTM™ SCS endurance therapy is an energy modified, differential target multiplexed therapy offering more longevity on Vanta™ recharge-free INS and rapid recharge on Intellis™ rechargeable INS. Three-month results show meaningful pain relief, satisfaction and quality of life improvements.2
Learn about Vanta™ SCS
Your advantage over pain
Vanta™ SCS gives you an advantage over pain. This high-performance, recharge-free device offers more longevity, DTM™ SCS endurance therapy, and unmatched MRI access.
Intellis™ SCS platform
The Intellis™ SCS is the world’s smallest implantable neurostimulator. This high-performance rechargeable device offers unrivaled battery chemistry with >95% battery capacity at 9 years, personalized programming and unmatched MRI access.
Fishman M, Cordner H, Justiz R, et al. 12-Month results from multicenter, open-label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain. Pain Pract. 2021. doi: 10.1111/papr.13066.
Peacock, Provenzano, Fishman, et al. A prospective multi-center study of a differential target multiplexed™ stimulation derivative in therapy-naive patients: Primary endpoint and 3-month outcomes. Poster presented at: North american neuromodulation society (NANS) annual meeting. Jan. 13-15, 2022.